AIM
CELG

Acrospire Investment Management’s Celgene Corp CELG Stock Holding History

Acrospire Investment Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-901
Closed -$117K – 2106
2017
Q2 		$117K Hold
901
– – 0.11% 166
2017
Q1 		$112K Sell
901
-2,800
-76% -$335K 0.09% 260
2016
Q4 		$428K Buy
3,701
+1,901
+106% +$212K 0.18% 45
2016
Q3 		$188K Buy
1,800
+800
+80% +$86.6K 0.13% 187
2016
Q2 		$99K Buy
1,000
+400
+67% +$41.4K 0.07% 464
2016
Q1 		$60K Buy
+600
New +$61.8K 0.04% 770

Other funds holding CELG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Acrospire Investment Management's CELG Position: Q3 2017 in Review

Acrospire Investment Management sold out of Celgene Corp (CELG) in Q3 2017, closing a stake of 901 shares — an estimated $117K sold.

Acrospire Investment Management first reported a position in CELG in Q1 2016 and held it in 6 quarters. The position peaked at $428K in Q4 2016. 1,484 funds tracked by Wall St. Rank hold CELG as of Q3 2017.

  • Acrospire Investment Management reported no remaining Celgene Corp position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 901 Celgene Corp shares in Q3 2017, an estimated $117K.
  • Acrospire Investment Management first reported a position in Celgene Corp in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Celgene Corp position peaked at $428K in Q4 2016.
  • 1,484 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.